DDW’s Megan Thomas spoke to key decision-makers from the drug discovery industry about their predictions on what 2022 holds for our sector, which can be downloaded and viewed for free from the DDW App for users of Apple or Android devices. “Carefully distinguishing true opportunities from passing fads will… Read More
This paid-for advertorial by TetraScience appeared in the DDW / SLAS supplement in DDW Volume 23, Issue 1 – Winter 2021/22 When Covid-19 arrived, every human being on the planet was affected. Within this crisis, scientists created new ways of collaborating and delivering vaccines… Read More
The Winter issue of the Drug Discovery World Magazine is accompanied by an exclusive DDW & SLAS2022 supplement ahead of SLAS2022 in Boston, US on 5-9 February. DDW Editor in Chief Lu Rahman comments. There is huge excitement within the DDW team regarding the SLAS2022 International Conference and Exhibition in Boston on 5-9… Read More
BenevolentAI, a clinical-stage AI drug discovery company, has expanded its AI-driven drug discovery collaboration with AstraZeneca, doubling the number of disease areas being explored through the partnership. The expansion The expansion builds on the collaboration initiated in 2019 and adds systemic lupus erythematosus (SLE) and… Read More
Sanford Burnham Prebys professor Andrei Osterman, Ph.D., has been awarded a $3.6 million grant from the National Institutes of Health (NIH) to expand current knowledge of antibiotic resistance, which will inform more precise antibiotic prescribing practices and help researchers develop drugs that are harder for bacteria to resist. Context… Read More
Listen to this article on the DDW Podcast: The Covid-19 Host Genetics Initiative carried out one of the largest genome-wide association studies ever. It involved meta-analysis of nearly 50,000 Covid-19 patients and two million uninfected controls. Dr Hamdi Mbarek, Lead Analyst of the Qatari dataset explains how the initiative… Read More
Sygnature Discovery, providers of drug discovery solutions, has appointed Dr Charles Woler as Chairman. Woler’s career Dr Woler has held multiple key roles in the sector, including CEO at Roche France, Executive Chairman for Europe at SmithKline Beecham, and CEO at Cadus Pharmaceutical in the US. Official comments … Read More
News round-up by DDW’s Megan Thomas for 10-14 January, 2022 Studies, approvals and research are at the heart of drug discovery, which has been exemplified in this week’s drug discovery news. Megan Thomas has rounded up her top five stories of the week. Vaccine-like mRNA injection can be… Read More
Collaboration within the drug discovery sector is well documented, says Lu Rahman. During the Covid-19 pandemic we have seen great examples. Take Pfizer and BioNTech or the work between Carterra and Eli Lilly Company to create bamlanivimab, a Covid-19 therapeutic. Collaborative work has created vaccines and therapeutics which are… Read More
With SLAS2022 confirmed to go ahead as both an in-person and hybrid event, the Innovation Award finalist presentations will take place on February 8, from 10AM- 5PM, and will be live-streamed to the online audience. What is the SLAS Innovation Award? The SLAS Innovation Award consists… Read More
Listen to this article on the DDW Podcast: Brad Loren, Matthew Marrone, and Christopher Singer, of intellectual property and technology law firm McAndrews, Held & Malloy, on quantum computing and its benefits to drug discovery. Explaining quantum computing and its promise Before we… Read More
Otsuka Pharmaceutical and Astex Pharmaceuticals’ oral fixed dose combination of decitabine and cedazuridine (ASTX727) for the treatment of Acute Myeloid Leukaemia (AML)1 has been granted orphan-drug designation (ODD) by the European Commission (EC). What is ALM? AML is the most common form of acute… Read More
Sanj Kumar outlines the positive role that digital technology has played in ELRIG events and how the organisation has harnessed the use of technology even when events have gone back to face-to-face. Scientific conferencing plays a key role in bringing together researchers and suppliers to share data, ideas and… Read More
The Winter issue of the Drug Discovery World Magazine is out now. Featuring Specialty Spotlight on Ophthalmology, the magazine is available to download and read for free on the DDW App. Key features of the Winter Issue include: How Quantum Computing Can Benefit Drug Discovery, Why The Emergence of Targeted Protein Degradation is So Exciting, plus exclusive interviews and… Read More
China-based Sinocompound Catalysts has partnered with InCatT to launch a specialist Catalyst Screening Service for pharmaceutical and fine chemical companies looking to optimise their reactions. The service The new service draws on InCatT’s experience in screening homogeneous catalysts combined with Sinocompound’s expertise in custom synthesis, scale-up and manufacturing of advanced catalysts and ligands. By combining… Read More
Discover how process optimisation utilising automated synthetic biology solutions can remove the antibody sequence cloning bottleneck that divides high-content lead identification and downstream high throughput characterisation. If your work involves antibody discovery or process improvement in recombinant cloning don’t miss this whitepaper illustrating how Codex DNA’s synthetic biology solutions can… Read More
